Scotiabank analyst George Farmer maintained a Buy rating on Adaptimmune Therapeutics (ADAP – Research Report) today and set a price target of ...

In a report released today, Justin Keywood from Stifel Nicolaus maintained a Buy rating on Knight Therapeutics (KHTRF – Research Report), with ...

Roche is to buy gene therapy firm Spark Therapeutics for $4.8 billion, adding an already-approved treatment for inherited blindness to its portfolio, and boosting its pipeline with a series of ...

Christmas has come a few days early for Spark Therapeutics after the FDA approved its ground-breaking gene therapy for a rare eye disease. It looked likely that the FDA would approve the US ...

The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...

TechCrunch has been sold off by Yahoo and StubHub has filed for an IPO. Twitter's iconic bird logo that was removed from the ...

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the ...

At close: March 20 at 4:00:01 PM EDT Loading Chart for ANTX ...

After hours: March 21 at 6:18:44 PM EDT Loading Chart for GALT ...